| [1] |
Fragkos M, Ganier O, Coulombe P, Méchali M. 2015. DNA replication origin activation in space and time. |
| [2] |
Matthews HK, Bertoli C, de Bruin RAM. 2022. Cell cycle control in cancer. |
| [3] |
Fei L, Xu H. 2018. Role of MCM2−7 protein phosphorylation in human cancer cells. |
| [4] |
Bellelli R, Boulton SJ. 2021. Spotlight on the replisome: aetiology of DNA replication-associated genetic diseases. |
| [5] |
Andrs M, Stoy H, Boleslavska B, Chappidi N, Kanagaraj R, et al. 2023. Excessive reactive oxygen species induce transcription-dependent replication stress. |
| [6] |
Li N, Gao N, Zhai Y. 2023. DDK promotes DNA replication initiation: mechanistic and structural insights. |
| [7] |
Saldivar JC, Cortez D, Cimprich KA. 2017. The essential kinase ATR: ensuring faithful duplication of a challenging genome. |
| [8] |
Song H, Guo Z, Xie K, Liu X, Yang X, et al. 2025. Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress. |
| [9] |
Kirova DG, Judasova K, Vorhauser J, Zerjatke T, Leung JK, et al. 2022. A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase. |
| [10] |
Enomoto T, Tanuma S, Yamada MA. 1981. ATP requirement for the processes of DNA replication in isolated HeLa cell nuclei. |
| [11] |
Somyajit K, Gupta R, Sedlackova H, Neelsen KJ, Ochs F, et al. 2017. Redox-sensitive alteration of replisome architecture safeguards genome integrity. |
| [12] |
Li X, Qian X, Jiang H, Xia Y, Zheng Y, et al. 2018. Nuclear PGK1 alleviates ADP-dependent inhibition of CDC7 to promote DNA replication. |
| [13] |
Juan CA, Pérez de la Lastra JM, Plou FJ, Pérez-Lebeña E. 2021. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies. |
| [14] |
Guertin DA, Wellen KE. 2023. Acetyl-CoA metabolism in cancer. |
| [15] |
Pan C, Li B, Simon MC. 2021. Moonlighting functions of metabolic enzymes and metabolites in cancer. |
| [16] |
Pai CC, Hsu KF, Durley SC, Keszthelyi A, Kearsey SE, et al. 2019. An essential role for dNTP homeostasis following CDK-induced replication stress. |
| [17] |
Buckland RJ, Watt DL, Chittoor B, Nilsson AK, Kunkel TA, et al. 2014. Increased and imbalanced dNTP pools symmetrically promote both leading and lagging strand replication infidelity. |
| [18] |
Bhat KP, Cortez D. 2018. RPA and RAD51: fork reversal, fork protection, and genome stability. |
| [19] |
Blackford AN, Jackson SP. 2017. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. |
| [20] |
Gupta N, Huang TT, Horibata S, Lee JM. 2022. Cell cycle checkpoints and beyond: exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancer. |
| [21] |
Petermann E, Woodcock M, Helleday T. 2010. Chk1 promotes replication fork progression by controlling replication initiation. |
| [22] |
Katsuno Y, Suzuki A, Sugimura K, Okumura K, Zineldeen DH, et al. 2009. Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. |
| [23] |
Toledo LI, Altmeyer M, Rask MB, Lukas C, Larsen DH, et al. 2013. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. |
| [24] |
Chabes A, Stillman B. 2007. Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae. |
| [25] |
Waters LS, Minesinger BK, Wiltrout ME, D'Souza S, Woodruff RV, et al. 2016. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. |
| [26] |
Sabouri N, Viberg J, Goyal DK, Johansson E, Chabes A. 2008. Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage. |
| [27] |
Lis ET, O'Neill BM, Gil-Lamaignere C, Chin JK, Romesberg FE. 2008. Identification of pathways controlling DNA damage induced mutation in Saccharomyces cerevisiae. |
| [28] |
Harada Y, Mizote Y, Suzuki T, Hirayama A, Ikeda S, et al. 2023. Metabolic clogging of mannose triggers dNTP loss and genomic instability in human cancer cells. |
| [29] |
Charbon G, Mendoza-Chamizo B, Campion C, Li X, Jensen PR, et al. 2021. Energy starvation induces a cell cycle arrest in Escherichia coli by triggering degradation of the DnaA initiator protein. |
| [30] |
Coster G, Frigola J, Beuron F, Morris EP, Diffley JFX. 2014. Origin licensing requires ATP binding and hydrolysis by the MCM replicative helicase. |
| [31] |
Klemm RD, Bell SP. 2001. ATP bound to the origin recognition complex is important for preRC formation. |
| [32] |
Kawakami H, Katayama T. 2010. DnaA, ORC, and Cdc6: similarity beyond the domains of life and diversity. |
| [33] |
Martin IV, MacNeill SA. 2002. ATP-dependent DNA ligases. |
| [34] |
Hardie DG, Ross FA, Hawley SA. 2012. AMPK: a nutrient and energy sensor that maintains energy homeostasis. |
| [35] |
Li S, Lavagnino Z, Lemacon D, Kong L, Ustione A, et al. 2019. Ca2+-stimulated AMPK-dependent phosphorylation of Exo1 protects stressed replication forks from aberrant resection. |
| [36] |
Kim SH, Kim SC, Ku JL. 2017. Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells. |
| [37] |
Somyajit K, Spies J, Coscia F, Kirik U, Rask MB, et al. 2021. Homology-directed repair protects the replicating genome from metabolic assaults. |
| [38] |
Chen Z, Odstrcil EA, Tu BP, McKnight SL. 2007. Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity. |
| [39] |
Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. 2010. ATM activation by oxidative stress. |
| [40] |
Sies H, Jones DP. 2020. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. |
| [41] |
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, et al. 2007. Free radicals and antioxidants in normal physiological functions and human disease. |
| [42] |
Pavlova NN, Thompson CB. 2016. The emerging hallmarks of cancer metabolism. |
| [43] |
Baker SA, Rutter J. 2023. Metabolites as signalling molecules. |
| [44] |
Trejo-Solís C, Serrano-García N, Castillo-Rodríguez RA, Robledo-Cadena DX, Jimenez-Farfan D, et al. 2024. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma. |
| [45] |
Li M, Rehman AU, Liu Y, Chen K, Lu S. 2021. Dual roles of ATP-binding site in protein kinases: orthosteric inhibition and allosteric regulation. |
| [46] |
He W, Li Q, Li X. 2023. Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer. |
| [47] |
Lan R, Wang Q. 2020. Deciphering structure, function and mechanism of lysine acetyltransferase HBO1 in protein acetylation, transcription regulation, DNA replication and its oncogenic properties in cancer. |
| [48] |
Chen G, Luo Y, Warncke K, Sun Y, Yu DS, et al. 2019. Acetylation regulates ribonucleotide reductase activity and cancer cell growth. |
| [49] |
Unnikrishnan A, Gafken PR, Tsukiyama T. 2010. Dynamic changes in histone acetylation regulate origins of DNA replication. |
| [50] |
Miotto B, Struhl K. 2010. HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by geminin. |
| [51] |
Feng Y, Vlassis A, Roques C, Lalonde M, González-Aguilera C, et al. 2016. BRPF3-HBO1 regulates replication origin activation and histone H3K14 acetylation. |
| [52] |
Li Q, Zhou H, Wurtele H, Davies B, Horazdovsky B, et al. 2008. Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. |
| [53] |
Das C, Lucia MS, Hansen KC, Tyler JK. 2009. CBP/p300-mediated acetylation of histone H3 on lysine 56. |
| [54] |
Fatoba ST, Tognetti S, Berto M, Leo E, Mulvey CM, et al. 2013. Human SIRT1 regulates DNA binding and stability of the Mcm10 DNA replication factor via deacetylation. |
| [55] |
Cazzalini O, Sommatis S, Tillhon M, Dutto I, Bachi A, et al. 2014. CBP and p300 acetylate PCNA to link its degradation with nucleotide excision repair synthesis. |
| [56] |
Zhang WJ, Zhou Y, Zhang Y, Su YH, Xu T. 2023. Protein phosphorylation: a molecular switch in plant signaling. |
| [57] |
Singh B, Wu PJ. 2019. Regulation of the program of DNA replication by CDK: new findings and perspectives. |
| [58] |
Masai H, Taniyama C, Ogino K, Matsui E, Kakusho N, et al. 2006. Phosphorylation of MCM4 by Cdc7 kinase facilitates its interaction with Cdc45 on the chromatin. |
| [59] |
Wang X, Liu L, Chen M, Quan Y, Zhang J, et al. 2024. S-CDK-regulated bipartite interaction of Mcm10 with MCM is essential for DNA replication. |
| [60] |
Chadha GS, Gambus A, Gillespie PJ, Blow JJ. 2016. Xenopus Mcm10 is a CDK-substrate required for replication fork stability. |
| [61] |
Tanaka S, Umemori T, Hirai K, Muramatsu S, Kamimura Y, et al. 2007. CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast. |
| [62] |
Dhingra N, Bruck I, Smith S, Ning B, Kaplan DL. 2015. Dpb11 protein helps control assembly of the Cdc45·Mcm2-7·GINS replication fork helicase. |
| [63] |
Barnieh FM, Morais GR, Loadman PM, Falconer RA, El-Khamisy SF. 2024. Hypoxia-responsive prodrug of ATR inhibitor, AZD6738, selectively eradicates treatment-resistant cancer cells. |
| [64] |
Chen Y, Poon RYC. 2008. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. |
| [65] |
Dai X, Ren T, Zhang Y, Nan N. 2021. Methylation multiplicity and its clinical values in cancer. |
| [66] |
Yazar V, Ruf WP, Knehr A, Günther K, Ammerpohl O, et al. 2023. DNA methylation analysis in monozygotic twins discordant for ALS in blood cells. |
| [67] |
Maleknia M, Ahmadirad N, Golab F, Katebi Y, Haj Mohamad Ebrahim Ketabforoush A. 2023. DNA methylation in cancer: epigenetic view of dietary and lifestyle factors. |
| [68] |
Bhat KP, Ümit Kaniskan H, Jin J, Gozani O. 2021. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. |
| [69] |
Mattei AL, Bailly N, Meissner A. 2022. DNA methylation: a historical perspective. |
| [70] |
Estève PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, et al. 2006. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. |
| [71] |
Unterberger A, Andrews SD, Weaver ICG, Szyf M. 2006. DNA methyltransferase 1 knockdown activates a replication stress checkpoint. |
| [72] |
Pryde F, Jain D, Kerr A, Curley R, Mariotti FR, et al. 2009. H3 K36 methylation helps determine the timing of Cdc45 association with replication origins. |
| [73] |
Tardat M, Brustel J, Kirsh O, Lefevbre C, Callanan M, et al. 2010. The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. |
| [74] |
A P, Xu X, Wang C, Yang J, Wang S, et al. 2018. EZH2 promotes DNA replication by stabilizing interaction of POLδ and PCNA via methylation-mediated PCNA trimerization. |
| [75] |
Du Q, Smith GC, Luu PL, Ferguson JM, Armstrong NJ, et al. 2021. DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity. |
| [76] |
Takebayashi SI, Ryba T, Wimbish K, Hayakawa T, Sakaue M, et al. 2021. The temporal order of DNA replication shaped by mammalian DNA methyltransferases. |
| [77] |
Kuo AJ, Song J, Cheung P, Ishibe-Murakami S, Yamazoe S, et al. 2012. The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier−Gorlin syndrome. |
| [78] |
Morales MM, Pratt MR. 2024. The post-translational modification O-GlcNAc is a sensor and regulator of metabolism. |
| [79] |
Yang X, Qian K. 2017. Protein O-GlcNAcylation: emerging mechanisms and functions. |
| [80] |
Forma E, Jóźwiak P, Bryś M, Krześlak A. 2014. The potential role of O-GlcNAc modification in cancer epigenetics. |
| [81] |
Banerjee PS, Lagerlöf O, Hart GW. 2016. Roles of O-GlcNAc in chronic diseases of aging. |
| [82] |
Xu S, Tong M, Suttapitugsakul S, Wu R. 2022. Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins. |
| [83] |
Zou Y, Pei J, Long H, Lan L, Dong K, et al. 2023. H4S47 O-GlcNAcylation regulates the activation of mammalian replication origins. |
| [84] |
Hayakawa K, Hirosawa M, Tani R, Yoneda C, Tanaka S, et al. 2017. H2A O-GlcNAcylation at serine 40 functions genomic protection in association with acetylated H2AZ or γH2AX. |
| [85] |
Xu Q, Yang C, Du Y, Chen Y, Liu H, et al. 2014. AMPK regulates histone H2B O-GlcNAcylation. |
| [86] |
Sakabe K, Wang Z, Hart GW. 2010. β-N-acetylglucosamine (O-GlcNAc) is part of the histone code. |
| [87] |
Leturcq M, Mortuaire M, Hardivillé S, Schulz C, Lefebvre T, et al. 2018. O-GlcNAc transferase associates with the MCM2−7 complex and its silencing destabilizes MCM−MCM interactions. |
| [88] |
Gamper AM, Rofougaran R, Watkins SC, Greenberger JS, Beumer JH, et al. 2013. ATR kinase activation in G1 phase facilitates the repair of ionizing radiation-induced DNA damage. |
| [89] |
Zhao J, Shao G, Lu X, Lv Z, Dong MQ, et al. 2024. O-GlcNAcylation of RPA2 at S4/S8 antagonizes phosphorylation and regulates checkpoint activation during replication stress. |
| [90] |
Guo D, Meng Y, Zhao G, Wu Q, Lu Z. 2025. Moonlighting functions of glucose metabolic enzymes and metabolites in cancer. |
| [91] |
Xu D, Shao F, Bian X, Meng Y, Liang T, et al. 2021. The evolving landscape of noncanonical functions of metabolic enzymes in cancer and other pathologies. |
| [92] |
Lu Z, Hunter T. 2018. Metabolic kinases moonlighting as protein kinases. |
| [93] |
Fornalewicz K, Wieczorek A, Węgrzyn G, Łyżeń R. 2017. Silencing of the pentose phosphate pathway genes influences DNA replication in human fibroblasts. |
| [94] |
Konieczna A, Szczepańska A, Sawiuk K, Węgrzyn G, Łyżeń R. 2015. Effects of partial silencing of genes coding for enzymes involved in glycolysis and tricarboxylic acid cycle on the enterance of human fibroblasts to the S phase. |
| [95] |
Saatchi F, Kirchmaier AL. 2019. Tolerance of DNA replication stress is promoted by fumarate through modulation of histone demethylation and enhancement of replicative intermediate processing in Saccharomyces cerevisiae. |
| [96] |
Schvartzman JM, Forsyth G, Walch H, Chatila W, Taglialatela A, et al. 2023. Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination. |
| [97] |
Sutendra G, Kinnaird A, Dromparis P, Paulin R, Stenson TH, et al. 2014. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. |
| [98] |
Zheng L, Roeder RG, Luo Y. 2003. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. |
| [99] |
Dai RP, Yu FX, Goh SR, Chng HW, Tan YL, et al. 2008. Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status. |
| [100] |
Stein A, Firshein W. 2000. Probable identification of a membrane-associated repressor of Bacillus subtilis DNA replication as the E2 subunit of the pyruvate dehydrogenase complex. |
| [101] |
Chen J, Zhang J, Zhu Y, Zhu Y, Pang J, et al. 2025. Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis. |
| [102] |
Soultanas P, Janniere L. 2023. The metabolic control of DNA replication: mechanism and function. |
| [103] |
Laffan J, Firshein W. 1987. Membrane protein binding to the origin region of Bacillus subtilis. |
| [104] |
Broxmeyer HE. 1979. Report on the 1978 annual meeting of the International Society of Experimental Hematology. |
| [105] |
Noirot-Gros MF, Dervyn E, Wu LJ, Mervelet P, Errington J, et al. 2002. An expanded view of bacterial DNA replication. |
| [106] |
Grosse F, Nasheuer HP, Scholtissek S, Schomburg U. 1986. Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex. |
| [107] |
Popanda O, Fox G, Thielmann HW. 1998. Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglycerate kinase. |
| [108] |
Rhee SG. 2016. Overview on peroxiredoxin. |
| [109] |
Nyström T, Yang J, Molin M. 2012. Peroxiredoxins, gerontogenes linking aging to genome instability and cancer. |
| [110] |
Wang A, Zou Y, Liu S, Zhang X, Li T, et al. 2024. Comprehensive multiscale analysis of lactate metabolic dynamics in vitro and in vivo using highly responsive biosensors. |
| [111] |
Zhao Y, Hu Q, Cheng F, Su N, Wang A, et al. 2015. SoNar, a highly responsive NAD+/NADH sensor, allows high-throughput metabolic screening of anti-tumor agents. |
| [112] |
Zhao Y, Wang A, Zou Y, Su N, Loscalzo J, et al. 2016. In vivo monitoring of cellular energy metabolism using SoNar, a highly responsive sensor for NAD+/NADH redox state. |
| [113] |
Moretti FA, Giardino G, Attenborough TCH, Gkazi AS, Margetts BK, et al. 2021. Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy. |
| [114] |
Lee N, Russell N, Ganeshaguru K, Jackson BFA, Piga A, et al. 1984. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase. |
| [115] |
Whitmore KV, Gaspar HB. 2016. Adenosine deaminase deficiency – more than just an immunodeficiency. |
| [116] |
Munk SHN, Merchut-Maya JM, Adelantado Rubio A, Hall A, Pappas G, et al. 2023. NAD+ regulates nucleotide metabolism and genomic DNA replication. |